Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
CYTOKINETICS Add to My Watchlist (NSDQ: CYTK) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Cytokinetics 2.95 -0.07 (-2.32%) 60,691
280 East Grand Avenue
South San Francisco, CA 94080 US
(650) 624-3000
(650) 624-3010 fax
www.cytokinetics.com
CEO Robert I. Blum
Auditor PRICEWATERHOUSECOOPERS LLP
Exchange Traded NQ
ISIN Number US23282W1009
CIK Number 1061983
NAICS Code 325412
Business Summary
A clinical-stage biopharmaceutical company, which focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
Number of Employees 110
Share Fundamentals
Market Cap 179.74M
Shares Outstanding 60.93M
Float 60.23M
Short Interest 1.46M
Financial Strength
Revenue (TTM) $81,538,000
Earnings (TTM) $24,544,000
Quick Ratio 6:1
Current Ratio 6.3:1
Total Debt/Equity 0.03:1
Profitability
Gross Margin N/A
EBITDA Margin 35.1%
Profit Margin 31.3%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs